OK Biotech Co., Ltd. (TPE:4155)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.95
+0.05 (0.39%)
Apr 29, 2026, 1:30 PM CST
-28.06%
Market Cap 1.82B
Revenue (ttm) 1.56B
Net Income (ttm) 82.45M
Shares Out 141.12M
EPS (ttm) 0.57
PE Ratio 22.65
Forward PE n/a
Dividend 0.30 (2.33%)
Ex-Dividend Date Jul 4, 2025
Volume 171,291
Average Volume 221,259
Open 13.00
Previous Close 12.90
Day's Range 12.85 - 13.00
52-Week Range 12.85 - 18.35
Beta 0.21
RSI 37.43
Earnings Date May 12, 2026

About OK Biotech

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OK... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4155
Full Company Profile

Financial Performance

In 2025, OK Biotech's revenue was 1.56 billion, a decrease of -6.81% compared to the previous year's 1.67 billion. Earnings were 82.45 million, a decrease of -12.26%.

Financial Statements

News

There is no news available yet.